Elizabeth Pike
Family · Inglis, FLNPI 1295022895
Payments from drug & device makers
Across 509 payments — averaging $18.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$1K
- Lilly USA, LLC$726
- GSK$653
- AstraZeneca$614
- Boehringer Ingelheim$486
- plus $4K from 30 others
What the payments were for
- Food & beverage$9,26999%
- Education$831%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 81 | $1,723 |
| Novo Nordisk | 94 | $1,399 |
| Lilly USA, LLC | 44 | $726 |
| GSK | 36 | $653 |
| AstraZeneca | 30 | $614 |
| Boehringer Ingelheim | 22 | $486 |
| Pfizer | 24 | $425 |
| Astellas Pharma US Inc | 17 | $384 |
| Amgen | 21 | $381 |
| Novartis | 17 | $297 |
| Johnson & Johnson | 23 | $289 |
| Sanofi-aventis U.S. LLC | 12 | $249 |
| Bayer | 11 | $220 |
| Exact Sciences | 8 | $159 |
| Amarin Pharma, Inc. | 7 | $154 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $147 |
| Vanda Pharmaceuticals Inc. | 6 | $144 |
| Lexicon Pharmaceuticals, Inc. | 7 | $129 |
| Esperion Therapeutics, Inc. | 6 | $127 |
| Merck | 5 | $89 |
| Insulet Corporation | 4 | $69 |
| Avanir Pharmaceuticals, Inc. | 4 | $66 |
| Biogen | 3 | $48 |
| Alkermes, Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $40 |
| Mylan Specialty L.p. | 2 | $40 |
| Idorsia Pharmaceuticals US Inc | 2 | $39 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $37 |
| Shield Therapeutics Inc | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Mannkind Corporation | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
How this compares
$9,352 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nystatin | 72 | $1,557 |
| Famotidine | 15 | $205 |
Paid to pharmacies, not to this prescriber.
Other family in Inglis
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.